Overview
Melanoma is a tumor that develops as a result of the
malignant transformation of melanocytes. These cells are derived from the
neural crest. Melanomas usually occur on the skin but can arise in other
locations where neural crest cells migrate, such as in the gastrointestinal
tract or brain. It is more common in women than in men. In women, the most
common site is the legs and melanomas in men are most common on the back.
Unusual moles, sores, lumps, blemishes, markings, or changes in the way an area
of the skin looks or feels are sign of melanoma. Treatment includes surgery,
radiation and proton therapy.
Click here for sample report @ http://www.wiseguyreports.com/sample-request/1555344-melanoma-pipeline-review-h1-2017
Report
Highlights
The Pharmaceutical and Healthcare latest pipeline guide
Melanoma - Pipeline Review, H1 2017, provides comprehensive information on the
therapeutics under development for Melanoma (Oncology), complete with analysis
by stage of development, drug target, mechanism of action (MoA), route of
administration (RoA) and molecule type. The guide covers the descriptive
pharmacological action of the therapeutics, its complete research and
development history and latest news and press releases.
The Melanoma (Oncology) pipeline guide also reviews of key
players involved in therapeutic development for Melanoma and features dormant
and discontinued projects. The guide covers therapeutics under Development by
Companies /Universities /Institutes, the molecules developed by Companies in
Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical,
Discovery and Unknown stages are 1, 20, 105, 120, 7, 214, 29 and 4
respectively. Similarly, the Universities portfolio in Phase III, Phase II,
Phase I, IND/CTA Filed, Preclinical and Discovery stages comprises 2, 14, 13,
1, 62 and 14 molecules, respectively.
Major Scope of the report:
- The pipeline guide provides a snapshot of the global
therapeutic landscape of Melanoma (Oncology).
- The pipeline guide reviews pipeline therapeutics for Melanoma (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Melanoma (Oncology) therapeutics and enlists all their major and minor projects.
- The pipeline guide reviews pipeline therapeutics for Melanoma (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Melanoma (Oncology) therapeutics and enlists all their major and minor projects.
Table of Contents
Table of Contents 2
Introduction 11
Melanoma - Overview 12
Melanoma - Therapeutics Development 13
Melanoma - Therapeutics Assessment 71
Melanoma - Companies Involved in Therapeutics Development 103
Melanoma - Drug Profiles 230
Melanoma - Dormant Projects 1675
Melanoma - Discontinued Products 1701
Melanoma - Product Development Milestones 1705
Appendix 1721
Introduction 11
Melanoma - Overview 12
Melanoma - Therapeutics Development 13
Melanoma - Therapeutics Assessment 71
Melanoma - Companies Involved in Therapeutics Development 103
Melanoma - Drug Profiles 230
Melanoma - Dormant Projects 1675
Melanoma - Discontinued Products 1701
Melanoma - Product Development Milestones 1705
Appendix 1721
.Continued
For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/1555344-melanoma-pipeline-review-h1-2017
About Us
Wise Guy
Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium
progressive statistical surveying, market research reports, analysis &
forecast data for industries and governments around the globe. Wise Guy Reports
understand how essential statistical surveying information is for your
organization or association. Therefore, we have associated with the top
publishers and research firms all specialized in specific domains, ensuring you
will receive the most reliable and up to date research data available.
Contact Us:
NORAH TRENT
Partner
Relations & Marketing Manager
Ph:
+1-646-845-9349 (US)
Ph: +44 208
133 9349 (UK)
